The most important effect of dihydroergotamine is venoconstriction, but certain metabolic effects and changes in vessel prostanoid activity have also been suggested. In this study endothelial cell production of 6-keto PGF1, and TxB z was quantitated in vitro. No evidence of altered prostanoid production was noted after incubation with dihydroergotarnine (exposure ranging from 5 x 10-3 to 5 x 10-v g/l). Similarly, no effect ofdihydroergotamine on the growth rates of endothelial cells or smooth muscle cells in vitro was documented.
Material and methods. Endothelial and smooth muscle cell derivation. Endothelial cells from dog external jugular veins
were harvested enzymatically with trypsin and collagenase as previously described by Ford et al. 8 . A homogeneous endothelial cell culture was ascertained by morphologic study and factor VIII expression. Smooth muscle cells were derived from canine carotid arteries. They were cleaned of adventitia and endothelium, minced, and placed into an enzyme solution of elastase type III and collagenase CLS type I. The high purity of the cell cultures was ascertained by morphological characterization, including presence of numerous myofilament bundles in the cytoplasm and vesicles near the membranes. For details of methodology see Lindblad et al. 11. Endothelial and smooth muscle cell growth rate determination.
Primary endothelial cell cultures, after 7-10 days growth, were trypsinized, pooled, passed and placed in serum-coated 16-mm culture wells (Costar, Cambridge, MA, USA), at a density of approximately 10,000 cells/well. The medium was medium 199, with 20 % fetal bovine serum (FlowLab, Rockville, MD, USA), gentamicin (5 gg/ml, Schering, Kenilworth, N J, USA), and a high concentration of endothelial cell growth factor (100 gg/ml, Seragen, Boston, MA, USA). No heparin was added to this medium. Dihydroergotamine mesylate (DHE 45, Sandoz Inc., East Hanover, NJ, USA) was added to the medium, at concentrations of 5 x 10-a; 5 x 10-4; 5 x 10-s; 5 x 10-6; and 5 x 10 -7 g/1. Medium without DHE served as a control. Sixteen wells were used for each DHE concentration studied. These DHE concentrations ranged from 1000 times higher to 10 times lower than the plasma concentration normally achieved in clinical settings. Addition of DHE did not affect the pH of the medium. The nutrient medium, with or without DHE, was changed every other day during the cultivation period. Smooth muscle cells, after primary cultivation, were trypsinized, pooled, washed, spun, and resuspended in medium as above. Into each 16-mm tissue culture well 8000 cells were plated. Different concentrations of DHE were added giving a final concentration of DHE ranging from 5 x 10-3 to 5 x 10-7 g/1. In a control group no DHE was added. Both endothelial and smooth muscle cell cultures were maintained in a 37 ~ incubator with a 100 % humidified atmosphere gas consisting of 5 % CO z and 95 % air. Initial seeding density was determined for 24 samples taken during plating. Plating efficiency was measured from 4 wells trypsinized at day 3. At the end of 7 days the remaining cells (12 wells) were trypsinized and counted using a Coulter ~ counter.
Endothelial cell prostanoid production. The endothelial cell culture medium was changed on day 6, and on day 7 the medium incubated for 24 h with the cells was removed and immediately frozen for later assay ofprostanoid production. Prostanoid metabolites were determined after extraction of proteins and free fatty acids 9.6-keto PGFI~ was determined utilizing a radioimmunoassay kit (New England Nuclear, detection limit 3.8 pg). TxB z was also determined by radioimmunoassay (New England Nuclear, detection limit 0.5 pg). The assays have low cross-reactivity to related prostanoids 9. Statistical analysis was performed with the Wilcoxon rank sum test. Mean values _+ SEM are given. (table) Endothelial cell prostanoid production. The 24-h incubated media had concentrations of 6-keto PGF1, of 3380 _+ 380 pg/ml in controls, and a range of 3160 + 425-3370 _ 510 pg/ml in DHE wells. TxB 2 levels were 5810 + 1020 pg/ ml in controls and ranged from 4210 + 1400 to 6960 + 1310 pg/ml in DHE wells. No significant differences existed between control medium and that to which DHE had been added.
Results. Endothelial cell growth
Discussion. In the current study we could not verify increased activity of prostanoids in vitro from cultured endothelial cells exposed to DHE. We have reported previously on the effects in vivo on healthy volunteers of indomethacin pretreatment before DHE administration. After pretreatment the same hemodynamic effects were observed as with no pretreatment; namely, increased venous flow velocity, reduced venous cross-sectional area, and reduced resting calf blood flow volume 6' ~o. These results, contrary to those of others, suggest little importance of prostanoids in the action of DHE. Measured under identical conditions, other agents show substantial variation in the prostanoid activity. Reduced release of prostanoids has been noted for acetylsalicylic acid (-55 %) and other cyclooxygenase and thromboxane inhibitors, whereas dipyridamole, a phosphodiesterase inhibitor, did not alter prostanoid activity, and thrombin administration increased prostanoid activity ~ 1. In addition to the direct vascular effects of DHE, metabolic alterations have also been ascribed to DHE. Included among these are reductions in liver glucose output, inhibition of adrenaline-induced hyperglycemia, stimulation of lipolysis, inhibition of cAMP degradation, interference with phosphodiesterase and increased pyruvate/lactate ratio during relative hypoxia 7' 12. Because of the potential effect of these changes on cell growth, we attempted to define whether there was any interaction between DHE and in vitro endothelial or smooth muscle plating efficiency and cell proliferation. Our data show that no such effect exists in this setting.
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Recently it has been claimed 1 that tetanus toxin does not inhibit the evoked release of [3H]noradrenaline from rat cerebral cortex slices. The statement contradicts our positive findings, obtained using two different experimental designs, on rat brain homogenate 2, 3. Using an improved superfusion system, we now show that both tetanus and, still better, botulinum A toxin prevent noradrenaline release. In contrast, the release of GABA, which is known as an inhibitory neurotransmitter, is inhibited preferentially by tetanus toxin.
Method. Rat brain cortex was cut into 0.3 x 0.3 mm prisms with a McIlwain chopper and suspended in Hepes (10 mM, pH 7.4) buffered ice-cold Krebs-Ringer solution (KRH). After a short trituration with an Eppendorfpipette, the suspension (10% w/v) was passed three times by hand through a Potter homogenizer with a loose-fitting pestle. After 3 min centrifugation at 4500 x g and washing once, the sediment was taken up to give 2% (w/v) with respect to original weight. For studying noradrenaline release, this suspension was mixed with half its volume of KRH containing (final concentration) noradrenaline (1 mCi/1, 1 p-M), iproniazid (10 p.M) and ascorbic acid (20 p-M). All subsequent solutions contained iproniazid and ascorbic acid. After 15 min shak-
